PMID: 3764630Jul 1, 1986Paper

Hepatitis due to herpes simplex virus in a nonpregnant patient: treatment with acyclovir

Sexually Transmitted Diseases
R P BaxterL Hoffman

Abstract

A previously healthy 19-year-old nonpregnant woman had disseminated infection with herpes simplex virus. The disseminated disease was accompanied by hepatitis. The patient was treated with parenteral acyclovir (5 mg/kg) given every 8 hr. The patient's symptoms resolved after three days of therapy. A review of five similar cases that were observed in healthy nonpregnant and nonimmunosuppressed individuals showed that all five patients died. Thus, rapid diagnosis of this potentially fatal condition is important, and the possible use of acyclovir for such cases should be considered.

Citations

Apr 7, 2006·Journal of Clinical Microbiology·Todd CzartoskiAnna Wald
Dec 1, 1994·Genitourinary Medicine·J J Sasadeusz, S L Sacks
Aug 21, 2004·Journal of Clinical Gastroenterology·Shobha Sharma, Mario Mosunjac
Aug 18, 2006·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A N DuckroH A Kessler
Sep 29, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·John P NorvellJosh Levitsky
Jan 1, 1988·Scandinavian Journal of Infectious Diseases·H GäbelK Ahlfors
Apr 1, 1993·Gastroenterologia Japonica·N TakebeM Tsuchiya
Feb 23, 2018·World Journal of Clinical Cases·Yoshihiro YokoiYoichi Watahiki
Nov 20, 1989·The Medical Journal of Australia·P C McMinnA Simmons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Y MiyazakiH Terao
JAMA : the Journal of the American Medical Association
M H RubinC J Painter
Journal of Medical Virology
G Y Minuk, L E Nicolle
The New England Journal of Medicine
David W Kimberlin, Dwight J Rouse
© 2021 Meta ULC. All rights reserved